Yusuke Kurioka
Yusuke Kurioka publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Surgery, on topics such as Gastric Cancer Management and Outcomes, Metastasis and carcinoma case studies and Gastrointestinal Tumor Research and Treatment.
- World rank
- #5,676,823 of 7,710,434 ranked researchers
- Rank in Japan
- #199,482 of 383,136
- Works
- 18
- Citations
- 83
- Citations per work
- 4.6
What does Yusuke Kurioka research?
Yusuke Kurioka's work is mostly in Medicine (83%), Biochemistry, Genetics and Molecular Biology (2%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1583.4%
- Medicine1583.4%
- Everything else314.7%
- Life Sciences01.9%
- 1Pulmonary and Respiratory Medicine32% of their works
- 2Oncology26% of their works
- 3Surgery17% of their works
- 4Gastroenterology6% of their works
- 5Hematology4% of their works
- 6Biotechnology2% of their works
Research topics
- Gastric Cancer Management and Outcomes
- Metastasis and carcinoma case studies
- Gastrointestinal Tumor Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Helicobacter pylori-related gastroenterology studies
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pancreatic and Hepatic Oncology Research
Which keywords describe Yusuke Kurioka's research?
The keywords of their largest research topics: Chemotherapy, Gastric Cancer, Endoscopic Resection, Molecular Characterization, Prognostic Factors, Surgical Management, Lung Tumors and Metastatic Carcinomas.
- Pancreatic Cancer
- PD-1 and PD-L1
- Inflammation
- Imatinib Mesylate
- Cholangiocarcinoma
- Biliary Tract Cancer
- Metastatic Carcinomas
- Surgical Management
- Molecular Characterization
- Gastric Cancer
- Chemotherapy
- Endoscopic Resection
- Prognostic Factors
- Lung Tumors
- Tumor Microenvironment
- Cetuximab
- Helicobacter pylori
- Immune Checkpoint Blockade
- KRAS Mutations
- Sunitinib
- Surgical Complications
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Chemotherapy173 topics
- Gastric Cancer152 topics
- Endoscopic Resection121 topic
- Molecular Characterization121 topic
- Prognostic Factors62 topics
- Surgical Management62 topics
- Lung Tumors51 topic
- Metastatic Carcinomas51 topic
- Tumor Microenvironment52 topics
- Biliary Tract Cancer31 topic
- Cetuximab31 topic
- Cholangiocarcinoma31 topic
- Helicobacter pylori31 topic
- Imatinib Mesylate31 topic
- Immune Checkpoint Blockade31 topic
- Inflammation31 topic
- KRAS Mutations31 topic
- PD-1 and PD-L131 topic
- Sunitinib31 topic
- Pancreatic Cancer21 topic
- Surgical Complications21 topic
Where does Yusuke Kurioka work?
Yusuke Kurioka's main affiliation in the publication record is Himeji Red Cross Hospital, Japan.
How many publications and citations does Yusuke Kurioka have?
OpenAlex counts 18 works and 83 citations for Yusuke Kurioka, an h-index of 5, ranking #5,676,823 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Yusuke Kurioka. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.